首页> 外国专利> PLASMA BIOMARKER FOR LIVER CANCER DIAGNOSIS COMPRISING LIVER CARBOXYLESTERASE 1 AND SCREENING METHOD FOR CANCER DIAGNOSIS

PLASMA BIOMARKER FOR LIVER CANCER DIAGNOSIS COMPRISING LIVER CARBOXYLESTERASE 1 AND SCREENING METHOD FOR CANCER DIAGNOSIS

机译:包括肝羧酸酯酶1的肝癌诊断的血浆生物标志物和癌诊断的筛选方法

摘要

A marker for diagnosing liver cancer of which expression is increased in plasma of patient is provided to detect a protein in plasma and early diagnose liver cancer by confirming the expression of protein. A composition of marker for diagnosing liver cancer comprises a liver-carboxyl esterase 1 protein in plasma as an active ingredient. The amount of the liver-carboxylesterase 1 protein of patient who suffers from liver cancer is more than that normal person in plasma. A method for screening liver cancer comprises: a first step of confirming the presence of the liver-carbxylesterase 1 from human blood sample using nano liquid chromatography and antibody immunoprecipitation; and a second step of detecting normal person and patient using immunoprecipitation, immnuoblotting, and nano liquid chromatography mass spectrometry.
机译:提供一种用于诊断在患者血浆中表达增加的肝癌的标志物,以检测血浆中的蛋白质并通过确认蛋白质的表达来早期诊断肝癌。用于诊断肝癌的标记物组合物包含血浆中的肝羧基酯酶1蛋白作为有效成分。患有肝癌的患者的肝脏中的羧酸羧酸酯酶1蛋白的量高于血浆中的正常人。一种筛查肝癌的方法,其包括:第一步,使用纳米液相色谱法和抗体免疫沉淀法,从人血样品中确认肝中的羰基酯酶1的存在;第二步是使用免疫沉淀,免疫印迹和纳米液相色谱质谱法检测正常人和患者。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号